Last time he was on, we were so interested in his institutional methodology and financialization, that we never got to discussing the pharmaceutical industry much.
So we’re having him on again today. Here are links to that show:
Last time he was on, we were so interested in his institutional methodology and financialization, that we never got to discussing the pharmaceutical industry much.
So we’re having him on again today. Here are links to that show: